Pediatric Vaccination
Pediatric Vaccination protects your child from savage sickness and also keeps other children safe by reducing serious illness that used to spread from child to child. Some of the recommended Pediatric Vaccines from birth to age 18 are DTaP (Diphtheria, Tetanus and Pertussis), Hepatitis A, Hepatitis B, Haemophilus Influenza Type b, Human Papillomavirus, Flu, Polio, MMR (Measles, Mumps and Rubella), Meningococcal, Pneumococcal, Rotavirus and Chickenpox.
- Diphtheria, tetanus, and whooping cough (pertussis) (DTaP)
- Polio (IPV)
- Measles, mumps, and rubella (MMR)
Related Conference of Pediatric Vaccination
March 24-25, 2026
9th International Conference on Vaccines, Immunology and Clinical Trials
Paris, France
August 27-28, 2026
7th International conference on Vaccines, Vaccination and Immunization
Paris, France
Pediatric Vaccination Conference Speakers
Recommended Sessions
- Adaptive immune system
- Autoimmune and Inflammatory Diseases
- Diabetes Vaccines
- Haematopoietic, Lymphoid Malignancies and Immune System Development
- HIV Vaccines
- How deadly is the Coronavirus?
- Human Vaccines-Infectious and Non Infectious
- Immunization and Bioterrorism
- Immunogenetics
- Immunotherapy
- Nanotechnology in Vaccine Delivery System
- Pediatric Vaccination
- Travel Immunization
- Vaccination for pregnant women
- Vaccine Adjuvants and Delivery Technologies
- Vaccines and Immunization
- Vaccines for Immune mediated Disease
- Vaccines for Unconventional Diseases
- Vaccines Preclinical and Clinical Trials
- Veterinary Vaccines
Related Journals
Are you interested in
- Adaptive Immunity and Immune Memory Formation - WORLD VACCINES 2026 (France)
- Adjuvants and Immune Modulation Strategies - WORLD VACCINES 2026 (France)
- Advancements in Vaccine Research and Development - Vaccines R&D 2026 (France)
- Advances in Pediatric Vaccines - Vaccines R&D 2026 (France)
- Adverse reactions to the vaccination - Vaccines Congress-2026 (UK)
- Animal & Plant Derived Vaccines - Vaccines-Immunization-2026 (France)
- Animal Models & Clinical Trials - Vaccines-Immunization-2026 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2026 (France)
- Antinatal vaccinations - Vaccines Congress-2026 (UK)
- Bacterial Vaccines and Toxoid Development - WORLD VACCINES 2026 (France)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2026 (France)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2026 (France)
- Clinical Trials Design and Methodologies - Vaccines R&D 2026 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2026 (France)
- Computational Immunology and Vaccine Modeling - WORLD VACCINES 2026 (France)
- Conjugated and combination vaccinations - Vaccines Congress-2026 (UK)
- Creation and development of vaccines - Vaccines Congress-2026 (UK)
- Current Research & Future Challenges - Vaccines-Immunization-2026 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2026 (France)
- DNA, RNA & SYNTHETIC VACCINES - Vaccines Congress-2026 (UK)
- Emerging and Re-Emerging Infectious Diseases - WORLD VACCINES 2026 (France)
- Emerging Infectious Diseases and Vaccine Development - Vaccines R&D 2026 (France)
- Ethical Considerations in Vaccine Development and Distribution - Vaccines R&D 2026 (France)
- Fish & Poultry Vaccines - Vaccines-Immunization-2026 (France)
- Future Directions in Vaccines and Immunology - WORLD VACCINES 2026 (France)
- Geriatric Immunization - Vaccines-Immunization-2026 (France)
- Global Immunization Strategies and Policy - Vaccines R&D 2026 (France)
- HIV , Malaria & TB vaccines - Vaccines Congress-2026 (UK)
- HIV Vaccines - Vaccines-Immunization-2026 (France)
- Immunogenetics and Host Immune Variability - WORLD VACCINES 2026 (France)
- Immunology of Infectious Diseases - Vaccines R&D 2026 (France)
- Immunopathology and Vaccine Safety - WORLD VACCINES 2026 (France)
- Immunotherapy and Personalized Medicine - Vaccines R&D 2026 (France)
- Innate Immune Responses in Vaccination - WORLD VACCINES 2026 (France)
- Innovations in Vaccine Cold Chain and Storage - Vaccines R&D 2026 (France)
- mRNA Vaccines and Nucleic Acid Platforms - WORLD VACCINES 2026 (France)
- Mucosal Immunity and Alternative Vaccine Routes - WORLD VACCINES 2026 (France)
- Paediatric Vaccination - Vaccines-Immunization-2026 (France)
- Pediatric and Geriatric Immunization Strategies - WORLD VACCINES 2026 (France)
- rDNA technology in vaccine development - Vaccines Congress-2026 (UK)
- Recent advances in vaccine development - Vaccines Congress-2026 (UK)
- Regulatory Approaches in Vaccine Development - Vaccines R&D 2026 (France)
- Regulatory Science and Vaccine Approval Pathways - WORLD VACCINES 2026 (France)
- Role of Adjuvants in Vaccine Efficacy - Vaccines R&D 2026 (France)
- Role of AI and Big Data in Vaccine Research - Vaccines R&D 2026 (France)
- The COVID-19 vaccine's next-generation RNA platforms and mRNA - Vaccines Congress-2026 (UK)
- Toxoid vaccination - Vaccines Congress-2026 (UK)
- Translational Immunology and Vaccine Development - Vaccines R&D 2026 (France)
- Translational Vaccinology from Research to Practice - WORLD VACCINES 2026 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2026 (France)
- Vaccine and Vaccination - Vaccines Congress-2026 (UK)
- Vaccine Biomarkers and Immune Correlates - WORLD VACCINES 2026 (France)
- Vaccine Delivery Systems and Targeting Approaches - WORLD VACCINES 2026 (France)
- Vaccine Delivery Systems: Innovations and Challenges - Vaccines R&D 2026 (France)
- Vaccine Design and Antigen Engineering - WORLD VACCINES 2026 (France)
- Vaccine Development for Cancer Immunotherapy - Vaccines R&D 2026 (France)
- Vaccine Development for Vector-Borne Diseases - Vaccines R&D 2026 (France)
- Vaccine efficiency and well-being - Vaccines Congress-2026 (UK)
- Vaccine Equity and Access in Low-Resource Settings - Vaccines R&D 2026 (France)
- Vaccine for infectious illnesses in humans - Vaccines Congress-2026 (UK)
- Vaccine Hesitancy and Public Perception - Vaccines R&D 2026 (France)
- Vaccine Manufacturing and Distribution - Vaccines R&D 2026 (France)
- Vaccine Manufacturing and Scale-Up Technologies - WORLD VACCINES 2026 (France)
- Vaccine manufacturing technologies - Vaccines Congress-2026 (UK)
- Vaccine Production & Development - Vaccines-Immunization-2026 (France)
- Vaccine Research and Clinical trials - Vaccines Congress-2026 (UK)
- Vaccine Safety and Pharmacovigilance - Vaccines R&D 2026 (France)
- Vaccine-Induced Cellular Immunity - WORLD VACCINES 2026 (France)
- Vaccines - Vaccines-Immunization-2026 (France)
- Vaccines & Autism - Vaccines-Immunization-2026 (France)
- Vaccines against Drugs - Vaccines-Immunization-2026 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2026 (France)
- Vaccines against non-traditional illnesses - Vaccines Congress-2026 (UK)
- VACCINES FOR CANCER - Vaccines Congress-2026 (UK)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2026 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2026 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2026 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2026 (France)
- Viral Vaccine Platforms and Vector Technologies - WORLD VACCINES 2026 (France)
- Zika Virus vaccines - Vaccines Congress-2026 (UK)